Ultralife (ULBI) Common Equity (2016 - 2025)
Ultralife has reported Common Equity over the past 16 years, most recently at $130.1 million for Q4 2025.
- Quarterly results put Common Equity at $130.1 million for Q4 2025, down 3.02% from a year ago — trailing twelve months through Dec 2025 was $130.1 million (down 3.02% YoY), and the annual figure for FY2025 was $130.1 million, down 3.02%.
- Common Equity for Q4 2025 was $130.1 million at Ultralife, down from $137.4 million in the prior quarter.
- Over the last five years, Common Equity for ULBI hit a ceiling of $138.6 million in Q2 2025 and a floor of $115.2 million in Q3 2022.
- Median Common Equity over the past 5 years was $121.6 million (2023), compared with a mean of $125.3 million.
- Biggest five-year swings in Common Equity: increased 11.42% in 2024 and later fell 3.02% in 2025.
- Ultralife's Common Equity stood at $117.6 million in 2021, then dropped by 2.06% to $115.2 million in 2022, then rose by 8.89% to $125.4 million in 2023, then grew by 6.98% to $134.2 million in 2024, then dropped by 3.02% to $130.1 million in 2025.
- The last three reported values for Common Equity were $130.1 million (Q4 2025), $137.4 million (Q3 2025), and $138.6 million (Q2 2025) per Business Quant data.